Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market

Lytix Biopharma AS (6BG) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Lytix Biopharma AS’s (6BG) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Lytix Biopharma AS is a Buy.
Lytix Biopharma AS’s (6BG) 20-Day exponential moving average is 0.73, while Lytix Biopharma AS’s (6BG) share price is €0.682, making it a Sell.
Lytix Biopharma AS’s (6BG) 50-Day exponential moving average is 0.67, while Lytix Biopharma AS’s (6BG) share price is €0.682, making it a Buy.

Lytix Biopharma AS (6BG) Pivot Points

Jul 25, 2024, 06:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.70
0.70
0.70
0.70
0.70
0.70
0.70
Fibonacci
0.70
0.70
0.70
0.70
0.70
0.70
0.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lytix Biopharma AS (6BG) Moving Averages

Jul 25, 2024, 06:24 PM
Period
Simple
Exponential
MA5
0.71Sell
0.71Sell
MA10
0.73Sell
0.72Sell
MA20
0.75Sell
0.73Sell
MA50
0.65Buy
0.67Buy
MA100
0.57Buy
0.62Buy
MA200
0.55Buy
0.60Buy
Lytix Biopharma AS’s (6BG) 10-Day exponential moving average is 0.72, while Lytix Biopharma AS’s (6BG) share price is €0.682, making it a Sell.
Lytix Biopharma AS’s (6BG) 100-Day exponential moving average is 0.62, while Lytix Biopharma AS’s (6BG) share price is €0.682, making it a Buy.
Lytix Biopharma AS’s (6BG) stock price is €0.682 and Lytix Biopharma AS’s (6BG) 50-day simple moving average is 0.65, creating a Buy signal.
Lytix Biopharma AS’s (6BG) stock price is €0.682 and Lytix Biopharma AS’s (6BG) 100-day simple moving average is 0.57, creating a Buy signal.
Lytix Biopharma AS’s (6BG) stock price is €0.682 and Lytix Biopharma AS’s (6BG) 200-day simple moving average is 0.55, creating a Buy signal.

Lytix Biopharma AS (6BG) Technical Indicators

Jul 25, 2024, 06:24 PM
Name
Value
Implied Action
RSI (14)
43.75
Neutral
STOCH (9,6)
2.27
Buy
STOCHRSI (14)
2.27
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
20.77
Neutral
Williams %R
-101.89
Buy
CCI (14)
-182.10
Buy
ATR (14)
0.02
-
Ultimate Oscillator
31.15
Neutral
ROC
-12.82
Sell
Lytix Biopharma AS’s (6BG) Relative Strength Index (RSI) is 43.75, creating a Neutral signal.
Lytix Biopharma AS’s (6BG) Trend Strength Indicator (ADX) is 20.77, creating a Neutral signal.
Lytix Biopharma AS’s (6BG) Commodity Channel Index (CCI) is -182.10, creating a Buy signal.
Lytix Biopharma AS’s (6BG) Price Rate of Change (ROC) is -12.82, creating a Sell signal.

FAQ

Is 6BG a Buy, Hold, or Sell?
Based on 6BG’s technical indicators, 6BG is a Buy.
    What is 6BG’s RSI (14)?
    6BG’s RSI (14) is 43.75, which suggests 6BG is a Neutral.
      What is 6BG’s MACD?
      6BG’s MACD is <0.01, which suggests 6BG is a Buy.
        What is 6BG’s 5-day moving average?
        6BG’s 5-day moving average is 0.71, which suggests 6BG is a Sell.
          What is 6BG’s 20-day moving average?
          6BG 20-day moving average is 0.75, which suggests 6BG is a Sell.
            What is 6BG’s 50-day moving average?
            6BG’s 50-day moving average is 0.65, which suggests 6BG is a Buy.
              What is 6BG’s 200-day moving average?
              6BG’s 200-day moving average is 0.55, which suggests 6BG is a Buy.
                What is 6BG’s Williams % R (14)?
                6BG’s Williams % R (14) is -101.89, which suggests 6BG is a Buy.
                  What is 6BG’s CCI (14)?
                  6BG’s CCI (14) is -182.10, which suggests 6BG is a Buy.
                    What is the share price of Lytix Biopharma AS?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis